Viking Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, March 29, 2023 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it intends to offer and sell shares of its…

Click here to view original post